Drugs

DeepMind spin-off steps up efforts to use AI to create new drugs

DeepMind spin-off steps up efforts to use AI to create new drugs

Alphabet-owned Isomorphic Labs is ramping up operations by poaching pharma talent and opening a new office as the artificial intelligence drug discovery startup nears closing its first commercial deal. The UK-registered group spun off from sister company DeepMind, Google’s AI unit, in November last year to focus on using AI technology to create new drugs …

DeepMind spin-off steps up efforts to use AI to create new drugs Read More »

AI helps design synthetic DNA that controls cell protein production

AI helps design synthetic DNA that controls cell protein production

With the help of an AI, researchers at Chalmers University of Technology in Sweden have succeeded in designing synthetic DNA that controls the production of proteins in cells. The technology can contribute to the development and production of vaccines, drugs for serious illnesses, as well as alternative dietary proteins much faster and at significantly lower …

AI helps design synthetic DNA that controls cell protein production Read More »